#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Neuronal ceroid lipofuscinosis Exudative retinopathy Haemophilia A with anti factor VIII Anal cancer recurrent Pyruvate kinase deficiency anaemia Dementia Alzheimer's type Hereditary motor and sensory neuropathy Pouchitis Oesophageal squamous cell carcinoma stage III Polymyositis Intracranial germ cell tumour Noonan syndrome Activated PI3 kinase delta syndrome Colitis ulcerative Extra-osseous Ewing's sarcoma More trials…

Learn about Rare Diseases

Leiomyosarcoma recurrent – Trials in Disease Tuberous sclerosis complex – Basic Information Krabbe’s disease – Trials in Disease Pleomorphic leiomyosarcoma – Treatment Thrombotic thrombocytopenic purpura – Life with Disease Osteosarcoma recurrent – Life with Disease Atypical haemolytic uraemic syndrome – Treatment Amyotrophic lateral sclerosis Angiosarcoma recurrent – Basic Information Piriformis syndrome – Basic Information More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Decitabine Pembrolizumab Dabrafenib Mesylate Bisacodyl Interferon Beta-1A Befiradol (18F) Afatinib Abbv-668 Niraparib Tosilate Monohydrate Tolcapone L-PHENYLALANINE Foscarnet Zofenopril Calcium E2814 Cilastatin Tabelecleucel Methohexital Sodium ZIRCONIUM (89ZR) GIRENTUXIMAB Tamuzimod Acetate TETRODOTOXIN More therapies…

Learn about Your Condition

Osteogenesis imperfecta Bronchopulmonary dysplasia Leber's congenital amaurosis Dyslipidaemia Rectal cancer Hyperparathyroidism primary Endometrial cancer stage II Sjogren's syndrome Cardiac disorder Diabetic nephropathy Oesophageal achalasia Bronchostenosis Transplantation complication Autoimmune hepatitis Prostate cancer recurrent More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Transitional cell carcinoma

Study of Subcutaneous Nivolumab with or without Recombinant Human Hyaluronidase PH20 for Patients with Lung, Kidney, Melanoma, Liver, Colorectal, or Bladder Cancer

Not recruiting

1 1 1 1
Investigated Drugs:
- Nivolumab
Study on Reduced BCG Dwell-Time for Patients with High-Risk Urothelial Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Transitional cell carcinoma

1 … 6 7 8

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Transitional cell carcinoma

Study of Subcutaneous Nivolumab with or without Recombinant Human Hyaluronidase PH20 for Patients with Lung, Kidney, Melanoma, Liver, Colorectal, or Bladder Cancer

Study on Reduced BCG Dwell-Time for Patients with High-Risk Urothelial Cancer

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies